Jayshree Nellore

Jayshree Nellore

Auto-generated profile, based on publicly available information

Jayshree Nellore

B Department of Biotechnology , Sathyabama University , Chennai , India

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 March 2013 in Journal of Neurodegenerative Diseases
Verified
Journal Article
Open access
PDF file
JNJayshree Nellore
Jayshree Nellore
CPCynthia Pauline
Cynthia Pauline
KAKanchana Amarnath
Kanchana Amarnath
Current discovery demonstrates the rapid formation of platinum nanoparticles using leaf extract of a neurobeneficial plant,Bacopa monnieri(BmE). The nanoparticles (BmE-PtNPs) were stabilized and then coated with varied phytochemicals present within the leaf extract. These nanoparticles demonstrated the same activity of Complex I, as that of oxidizing NADH to NAD+using a spectrophotometric method. This suggests that BmE-PtNPs are a potential medicinal substance for oxidative stress mediated disease with suppressed mitochondrial complex I, namely, Parkinson's disease (PD). Hence, the neuroprotective potentials of the phytochemical coated nanoparticle were explored in 1-methyl 4-phenyl 1,2,3,6 tetrahydropyridine- (MPTP-)induced experimental Parkinsonism in zebrafish model. BmE-PtNPs pretreatment significantly reversed toxic effects of MPTP by increasing the levels of dopamine, its metabolites, GSH and activities of GPx, catalase, SOD and complex I, and reducing levels of MDA along with enhanced locomotor activity. Taken together, these findings suggest that BmE-PtNPs have protective effect in MPTP-induced neurotoxicity in this model of Parkinson's disease via their dual functions as mitochondrial complex I and antioxidant activity.

31 March 2017 in Artificial Cells, Nanomedicine, and Biotechnology
Verified
Journal Article
Closed access
PSPradeep Pushparaj Selvadoss
Pradeep Pushparaj Selvadoss
JNJayshree Nellore
Jayshree Nellore
MRMalathy Balaraman Ravindrran
Malathy Balaraman Ravindrran
USUma Sekar
Uma Sekar
JTJayakrishna Tippabathani
Jayakrishna Tippabathani
In this study, we examined the efficacy of liposomal oleic acid-based antibiotic formulations on 32 strains of multidrug-resistant Pseudomonas aeruginosa (MDRPa). The average size of liposomes were 93.12 ± 2.3 nm holding a negative zeta potential at −57.3 ± 0.89. Liposomal antibiotic formulations were tested against 32 MDRPa strains isolated from burn wounds and urine samples, which exhibited an MIC of ≤8 μg/mL, whereas MIC of free antibiotics ranged from 32 to >1024 μg/mL. The results clearly indicate that the liposomes composed of naturally occurring oleic acid, could be used therapeutically either alone or in combination with antibiotics to effectively treat P. aeruginosa infections.

1 April 2012 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
KAKanchana Amarnath
Kanchana Amarnath
JKJayanthi Kumar
Jayanthi Kumar
TRTejesh Reddy
Tejesh Reddy
VMVakka Mahesh
Vakka Mahesh
SASenniyanallur Rathakrishnan Ayyappan
Senniyanallur Rathakrishnan Ayyappan
JNJayshree Nellore
Jayshree Nellore

1 January 2015 in Toxicology Reports
Verified
Journal Article
Open access
JNJayshree Nellore
Jayshree Nellore
NPNandita P.
Nandita P.
Exposure to environmental risk factors such as herbicides in early life has been proposed to play important roles in the development of neurodegenerative disorders in adult life. To test this hypothesis, we used a zebrafish model to link the herbicide paraquat (PQ) to disease etiology. Strikingly, treatment of 18 hpf embryonic zebrafish with low-dose PQ treatment (0.04 ppm, lower than the accepted human daily exposure) resulted in 50% display of neurodegenerative phenotypes and motor deficits at various developmental stages (segmentation to larval stage). Wide arrays of biomarkers have been employed to delineate the toxic responses which include lipid peroxidation, glutathione (GSH) and apoptosis studies. A decrease in the GSH levels, increase in lipid peroxidation and apoptosis, respectively, were observed at various developmental stages. Unexpectedly, we show that the exposure to paraquat during the window of dopamine neurogenesis causes Parkinsonian like motor defects in later life by perturbing cholinergic system due to oxidative stress.

15 September 2011 in Cancer Nanotechnology
Verified
Journal Article
Open access
PDF file
KAKanchana Amarnath
Kanchana Amarnath
NMNina Liza Mathew
Nina Liza Mathew
JNJayshree Nellore
Jayshree Nellore
CSChagam Reddy Venkat Siddarth
Chagam Reddy Venkat Siddarth
JKJayanthi Kumar
Jayanthi Kumar
The remarkable health benefits of the chemical cocktails occluded within Vites vinefera (grapes) have been broadly used as dietary supplements and as natural pharmaceuticals in the treatment of various diseases including human cancer. Current discovery demonstrates the rapid formation of gold nanoparticles with the phytochemicals present in grapes, which serve a dual role as synergistic reducing agents to reduce gold salts into gold nanoparticles and also as stabilizers to provide a robust coating on the gold nanoparticles in a single step. Furthermore, the grape-generated gold nanoparticles (GAuNPs), have demonstrated remarkable in vitro stability on specific functionalization with peptides (GSH) and thiol-containing compounds (lipoic acid) followed by the induction of cell-specific response. In addition, the grape-generated gold nanoparticles (GAuNPs, GSH-GAuNPs, LA-GAuNPs) have demonstrated remarkable affinity towards human breast cancer cells (HBL-100) in the present study. These studies thus signified the cellular internalization of GAuNPs and its conjugates by transmission electron microscopy through endocytosis into cancer cells. Notably, at higher concentration of gold nanoparticles conjugate, there was an asymmetric accumulation of gold nanoparticles in the periphery of the cell nucleus of the HBL-100 cells which was confirmed by fluorescence microscopy. Other than gold salts, no “manmade” chemicals are used in this truly biogenic, green nanotechnological process which thereby paves the way for outstanding opening for their application in molecular imaging and cancer therapy.

7 August 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
DLDarshan Narendrabhai Ladva
Darshan Narendrabhai Ladva
PSPradeep Pushparaj Selvadoss
Pradeep Pushparaj Selvadoss
GCGrishma Kantibhai Chitroda
Grishma Kantibhai Chitroda
SDSivaraman Dhanasekaran
Sivaraman Dhanasekaran
JNJayshree Nellore
Jayshree Nellore
SSSundar Manoharan Solomon
Sundar Manoharan Solomon
Antibiotic resistance is a significant threat, leaving us vulnerable to bacterial infections. Novel strategies are needed to combat bacterial resistance beyond discovering new antibiotics. This research focuses on using maleimide conjugated PEGylated liposomes (Mal-PL-Ab) to individually encapsulate a variety of antibiotics (ceftriaxone, cephalexin, doxycycline, piperacillin, ampicillin, and ceftazidime) and enhance their delivery against multi-drug resistant (MDR) bacteria like Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae). Mal-PL-Ab, with an average size of 84.2 nm ± 4.32 nm, successfully encapsulated these antibiotics with an encapsulation efficiency of 37.73 ± 3.19%. Compared to non-PEGylated liposomes (L-Ab), Mal-PL-Ab exhibited reduced toxicity in human dermal cells, emphasizing the importance of PEGylation in minimizing adverse effects. Mal-PL-Ab significantly decreased the minimum inhibitory concentration (MIC) values against both E. coli and K. pneumoniae by 9.33-fold and eightfold reduction (compared to non-PEGylated liposomes with 2.33-fold and 2.33fold reduction), respectively, indicating enhanced efficacy against MDR strains. Furthermore, in vitro scratch assay and gene expression analysis of human dermal fibroblast revealed that Mal-PL-Ab promoted cell proliferation, migration, and wound healing through upregulation of cell cycle, DNA repair, and angiogenesis-related genes. Harnessing the power of encapsulation, Mal-PL-Ab presents a novel avenue for enhanced antibiotic delivery and wound healing, potentially transcending the limitations of traditional options.